Category: Finance
-
$1M Challenge Aims to Monitor DNA/RNA Sequencing of a Cell
Life Technologies in Carlsbad, California unveiled a competition to enhance its current genomic sequencing capabilities to monitor the genome and transcriptome — corresponding ribonucleic acid (RNA) molecules — derived from a single human cancer cell. The company is offering a $1 million prize through a challenge on InnoCentive, a company that runs these crowd-sourcing competitions.…
-
Grant to Fund Research on Ice-Resistant Coatings
University of Illinois at Chicago engineering professor Constantine Megaridis recently received a $320,000 National Science Foundation grant to investigate coatings that can resist the build up of ice. Megaridis’s research is expected to continue his previous research on coatings that are both superhydrophobic — have the ability to repel water — and self-cleaning. At UIC,…
-
Diagnostics Company Gets State Grant for Blood Platelet Test
Immunetics Inc. in Boston, Massachusetts, received a Small Business Matching Grant (SBMG) to commercialize its BacTx test for detecting bacterial contamination in blood platelets. The Massachusetts Life Sciences Center made the $500,000 award. Platelets enable clotting, and patients suffering from trauma, surgical procedures, cancer, or chemotherapy must receive platelet transfusions to survive. The company says…
-
Solvay to Form Research Center at Korean Women’s University
Solvay, a chemical company in Brussels, Belgium, says it will locate its Korean research center on the campus of EWHA Women’s University in Seoul. The company’s investment in this venture will total EUR 16.8 million (USD 24.0 million). Solvay plans to invest EUR 13 million in a Research, Development and Technology (RDT) Centre at EWHA.…
-
State, Industry Funding Support University Solar Center
The State of Ohio and several companies are contributing funds for an R&D center at Case Western Reserve University in Cleveland to boost the lifetime of solar energy technologies. The Solar-Durability and Lifetime Extension (S-DLE) Center at Case Western Reserve will have labs and test facilities to evaluate materials and components under extreme conditions. The…
-
Challenge Seeks Faster, Simpler Crop Analysis Methods
A new challenge on InnoCentive seeks better tools for farmers to evaluate their management practices and improve the use of fertilizer and other crop inputs. The competition, sponsored by the Environmental Defense Fund and the Iowa Soybean Association, will award a $15,000 prize to the winning entry. The deadline for the challenge is 13 August…
-
$100 Million Investment Fund Set for Second-Stage Companies
Stage 2 Innovations, a new venture capital fund, and Automation Alley, a technology business group in Troy, Michigan, will identify companies for funding to support large-scale commercialization. The fund will support entrepreneurs with proven technologies that need financing to take their discoveries to the global market. Tom LaSorda (pictured right), former President and CEO of…
-
University, Company Engineers Research Safer Railroad Ties
Engineers at Kansas State University in Manhattan and the company CXT Concrete Ties in Tucson, Arizona have received funding for research leading to safer railroad ties to support the nation’s new high-speed rail projects. The engineering team was awarded a grant for nearly $900,000 from the Federal Railroad Administration, with another $300,000 provided by CXT…
-
Timken, College to Build Wind Energy R&D Center
The Timken Company in Canton, Ohio revealed plans for a new research and development center for wind turbine mechanisms used to generate electricity. The $11.8 million facility, built in collaboration with nearby Stark State College, is expected to add 65 new jobs. The R&D center will focus on wind turbine mechanisms that convert wind power…
-
Lilly Spins Off Biotech to Develop Sepsis Drug
Eli Lilly and Company in Indianapolis, Indiana has signed agreements with private investors Care Capital and NovaQuest Capital to establish BioCritica Inc., a new biotechnology company. BioCritica will initially focus on the continued U.S. development and commercialization of Xigris — drotrecogin alfa (activated) — Lilly’s medicine for severe sepsis. Under the agreement, BioCritica will acquire…